Italian generics specialist Doc Generici says it is “expanding its strategy, broadening its business lines, and defining a new vision,” after acquiring a local nutraceuticals firm and rebranding under the name DOC Pharma.
Doc Generici Becomes DOC Pharma As Diversification Continues
Italian Generics Specialist Acquires Nutraceuticals Firm Geopharma Under New Banner
A journey began eight years ago continues for Doc Generici – now rebranded as DOC Pharma – as it continues to diversify its offerings beyond conventional generic prescription pharmaceuticals.
More from Deals
• By
By taking a majority stake in dynamic dietary supplements firm Braineffect, Germany's Schwabe can reach a new, younger target audience for its OTC herbal medicines.
• By
Direct seller has deals to fully acquire and 51% ownership of Link BioSciences, which formulates personalized supplements. It also announced a deal to acquire Pruvit Ventures, ketone supplements direct seller.
• By
Australia's SFI Health looking to take Equazen omega-3 fatty acids supplement to new markets to capitalize on Europe's fast-growing brain health segment.
• By
A journey began eight years ago continues for Doc Generici – now rebranded as DOC Pharma – as it continues to diversify its offerings beyond conventional generic prescription pharmaceuticals.
More from Strategy
• By
A week after announcing 2024 full-year and fourth-quarter results, the firm says its corporate name will be Niagen Bioscience Inc. starting 19 March. It stated in its latest results that during 2024 it launched Niagen Plus line of pharmaceutical-grade Niagen.
• By
Ashley Graham promotes OLLY; Robles BioCeutics adds financial and science chiefs; Graham Rigby leads AHPA; Vit-Best Nutrition appoints Jeffrey Stallings president; BodyHealth collaborates with NBA player Bam Adebayo; and Bucked Up adds Alex Eubank as brand ambassador.
• By
Australia's SFI Health looking to take Equazen omega-3 fatty acids supplement to new markets to capitalize on Europe's fast-growing brain health segment.